Viewing Study NCT05746559


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2025-12-26 @ 12:16 AM
Study NCT ID: NCT05746559
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2023-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module